ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 160 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,374,000 | +3.0% | 334,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,334,000 | +44.7% | 334,300 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $922,000 | -7.5% | 341,300 | -5.8% | 0.00% | 0.0% |
| Q2 2020 | $997,000 | +17.4% | 362,471 | +0.8% | 0.00% | 0.0% |
| Q1 2020 | $849,000 | -49.1% | 359,571 | +1.3% | 0.00% | -50.0% |
| Q4 2019 | $1,668,000 | +94.9% | 354,871 | +38.6% | 0.00% | +100.0% |
| Q3 2019 | $856,000 | +23.3% | 255,971 | +21.3% | 0.00% | 0.0% |
| Q2 2019 | $694,000 | -53.1% | 210,995 | -56.8% | 0.00% | -50.0% |
| Q1 2019 | $1,481,000 | +11.4% | 488,795 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,330,000 | -19.0% | 488,795 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,642,000 | +31.6% | 488,795 | +1.1% | 0.00% | 0.0% |
| Q2 2018 | $1,248,000 | -29.5% | 483,600 | -39.9% | 0.00% | -33.3% |
| Q1 2018 | $1,771,000 | +10.5% | 805,200 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $1,602,000 | -49.2% | 805,200 | -17.2% | 0.00% | -60.0% |
| Q3 2017 | $3,152,000 | +4.8% | 972,694 | +4.1% | 0.01% | 0.0% |
| Q2 2017 | $3,008,000 | +13.4% | 934,300 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $2,653,000 | +39.3% | 934,300 | +14.4% | 0.00% | +33.3% |
| Q4 2016 | $1,904,000 | +277.8% | 817,000 | +172.4% | 0.00% | +200.0% |
| Q3 2016 | $504,000 | +49.6% | 299,900 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $337,000 | +17.0% | 320,500 | -3.0% | 0.00% | – |
| Q1 2016 | $288,000 | -32.1% | 330,500 | -5.7% | 0.00% | -100.0% |
| Q4 2015 | $424,000 | -28.9% | 350,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $596,000 | -21.0% | 350,400 | -3.3% | 0.00% | 0.0% |
| Q2 2015 | $754,000 | -11.4% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $851,000 | 0.0% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $851,000 | +28.4% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $663,000 | -31.4% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $967,000 | -18.3% | 362,300 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $1,184,000 | -21.3% | 362,300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,504,000 | +1.1% | 362,300 | -1.2% | 0.00% | -33.3% |
| Q3 2013 | $1,488,000 | +9.9% | 366,600 | +12.7% | 0.00% | 0.0% |
| Q2 2013 | $1,354,000 | – | 325,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |